<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>Mathematical Modeling of the Chemotherapy, Immunotherapy and Vaccine Therapy of Cancer</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>09/01/2004</AwardEffectiveDate>
<AwardExpirationDate>08/31/2008</AwardExpirationDate>
<AwardTotalIntnAmount>328283.00</AwardTotalIntnAmount>
<AwardAmount>328283</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>03040100</Code>
<Directorate>
<Abbreviation>MPS</Abbreviation>
<LongName>Direct For Mathematical &amp; Physical Scien</LongName>
</Directorate>
<Division>
<Abbreviation>DMS</Abbreviation>
<LongName>Division Of Mathematical Sciences</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Michael Steuerwalt</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>     The investigators bring together expertise in the areas of&lt;br/&gt;differential equations and numerics, differential geometry, and&lt;br/&gt;optimal control with the goal of developing mathematical modeling&lt;br/&gt;and analysis tools applied to the creation and testing of new&lt;br/&gt;combinations of chemo-immunotherapies for treating cancer.  The&lt;br/&gt;investigators, together with their students, carry out work along&lt;br/&gt;three complementary paths.  First, dynamical systems population&lt;br/&gt;models are created and analyzed to determine fundamental system&lt;br/&gt;behavior that helps guide the development of combination&lt;br/&gt;therapies.  Second, differential geometry approaches allow for&lt;br/&gt;the analysis of idealized geometric forms approximating physical&lt;br/&gt;structures of spherical, cylindrical, elliptic, and harmonic&lt;br/&gt;spherical tumors, which can closely approximate certain in vivo&lt;br/&gt;tumor geometries.  Third, optimal control theory is used to&lt;br/&gt;reveal paths to new optimal combination therapies with&lt;br/&gt;implementation of a variety of constraints to minimize tumor&lt;br/&gt;burden while keeping the patient's immune and normal cell&lt;br/&gt;populations above a healthy threshold.  The results of these&lt;br/&gt;investigations have the potential to provide guidance in the&lt;br/&gt;structuring of improved patient-specific treatment protocols. &lt;br/&gt;&lt;br/&gt;     The mathematical modeling of cancer growth and combination&lt;br/&gt;treatment strategies adds to our basic understanding of cancer&lt;br/&gt;response mechanisms in fundamental ways.  The simulations,&lt;br/&gt;geometric visualization, and optimization the investigators&lt;br/&gt;undertake allow for an array of virtual experiments to be run&lt;br/&gt;that can be performed quickly with no risk to living persons, but&lt;br/&gt;that provide data that can significantly benefit medical decision&lt;br/&gt;making.  The modeling of cancer growth and treatment requires&lt;br/&gt;skills from multiple disciplines.  A major outcome of this&lt;br/&gt;project is the development of software for simulating and&lt;br/&gt;visualizing cancer growth and treatment pathways, involving&lt;br/&gt;chemotherapy and immunotherapy, which can result in the creation&lt;br/&gt;of new mathematically guided patient-specific combination&lt;br/&gt;treatment strategies.  This work lies at the intersection of&lt;br/&gt;information technology and biotechnology, with mathematics at the&lt;br/&gt;core.  The investigators have the ability to funnel discoveries&lt;br/&gt;for new treatment strategies suggested by the mathematics&lt;br/&gt;directly to collaborating clinical oncologists through the&lt;br/&gt;ongoing meetings of a California-based Mathematics of Medicine&lt;br/&gt;Study group. In turn, the physicians in this group can enhance&lt;br/&gt;the development of the mathematical models by sharing outcomes of&lt;br/&gt;ongoing clinical trials.  The investigators directly involve&lt;br/&gt;undergraduates in the multiple facets of this cutting-edge&lt;br/&gt;endeavor through research assistantships, courses, and&lt;br/&gt;independent study.  A unique aspect of this project is the&lt;br/&gt;collaboration of three women investigators who are attracting&lt;br/&gt;more women students to this area of research.  The investigators&lt;br/&gt;as a team can serve as role models on the forefront of the fight&lt;br/&gt;against cancer, and in particular are in a good position to&lt;br/&gt;affect breast cancer studies, which are of special importance to&lt;br/&gt;women's health.  The results from solving the challenging&lt;br/&gt;mathematical, computational and biological problems of this&lt;br/&gt;project are made publicly accessible through publications and&lt;br/&gt;web-based postings.  This collaborative effort has the potential&lt;br/&gt;to help clinicians save lives and reduce the suffering of cancer&lt;br/&gt;patients. &lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>08/26/2004</MinAmdLetterDate>
<MaxAmdLetterDate>08/26/2004</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.049</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0414011</AwardID>
<Investigator>
<FirstName>Lisette</FirstName>
<LastName>de Pillis</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Lisette de Pillis</PI_FULL_NAME>
<EmailAddress>depillis@hmc.edu</EmailAddress>
<PI_PHON/>
<NSF_ID>000470209</NSF_ID>
<StartDate>08/26/2004</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Weiqing</FirstName>
<LastName>Gu</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Weiqing Gu</PI_FULL_NAME>
<EmailAddress>gu@math.hmc.edu</EmailAddress>
<PI_PHON>9096218929</PI_PHON>
<NSF_ID>000362626</NSF_ID>
<StartDate>08/26/2004</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Harvey Mudd College</Name>
<CityName>CLAREMONT</CityName>
<CountyName>LOS ANGELES</CountyName>
<ZipCode>917115901</ZipCode>
<PhoneNumber>9096218121</PhoneNumber>
<StreetAddress>301 Platt Boulevard</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
<CONGRESSDISTRICT>27</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>CA27</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>066691130</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>HARVEY MUDD COLLEGE</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM>066691130</ORG_PRNT_DUNS_NUM>
</Institution>
<Performance_Institution>
<Name>Harvey Mudd College</Name>
<CityName>CLAREMONT</CityName>
<CountyName>LOS ANGELES</CountyName>
<StateCode>CA</StateCode>
<ZipCode>917115901</ZipCode>
<StreetAddress>301 Platt Boulevard</StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>27</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>CA27</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0000099</Code>
<Name>Other Applications NEC</Name>
</FoaInformation>
<ProgramElement>
<Code>1271</Code>
<Text>COMPUTATIONAL MATHEMATICS</Text>
</ProgramElement>
<ProgramElement>
<Code>7334</Code>
<Text>MATHEMATICAL BIOLOGY</Text>
</ProgramElement>
<ProgramReference>
<Code>0000</Code>
<Text>UNASSIGNED</Text>
</ProgramReference>
<ProgramReference>
<Code>7334</Code>
<Text>MATHEMATICAL BIOLOGY</Text>
</ProgramReference>
<ProgramReference>
<Code>9229</Code>
<Text>RES IN UNDERGRAD INST-RESEARCH</Text>
</ProgramReference>
<ProgramReference>
<Code>9251</Code>
<Text>REU SUPP-Res Exp for Ugrd Supp</Text>
</ProgramReference>
<ProgramReference>
<Code>9263</Code>
<Text>COMPUTATIONAL SCIENCE &amp; ENGING</Text>
</ProgramReference>
<ProgramReference>
<Code>OTHR</Code>
<Text>OTHER RESEARCH OR EDUCATION</Text>
</ProgramReference>
<Appropriation>
<Code>0104</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2004~328283</FUND_OBLG>
</Award>
</rootTag>
